Future research and development efforts can focus on two main directions: analyzing the molecular networks regulating ferroptosis in immune cells (such as TAMs and Tregs) within the tumor microenvironment (TME); and conducting precision clinical trials based on biomarkers (such as ACSL4 and SLC7A11). The gene discussed is ACSL4; the disease is neoplasm.